Home
>
National Drug Code (NDC)
>
Brimonidine Tartrate
Brimonidine Tartrate - 61314-143-05 - (Brimonidine Tartrate)
Drug Information of Brimonidine Tartrate
| Product NDC: | 61314-143 |
| Proprietary Name: | Brimonidine Tartrate |
| Non Proprietary Name: | Brimonidine Tartrate |
| Active Ingredient(s): | 2 mg/mL & nbsp; Brimonidine Tartrate |
| Administration Route(s): | OPHTHALMIC |
| Dosage Form(s): | SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Brimonidine Tartrate
| Product NDC: | 61314-143 |
| Labeler Name: | Falcon Pharmaceuticals, Ltd. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA076254 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20030917 |
Package Information of Brimonidine Tartrate
| Package NDC: | 61314-143-05 |
| Package Description: | 5 mL in 1 BOTTLE (61314-143-05) |
NDC Information of Brimonidine Tartrate
| NDC Code | 61314-143-05 |
| Proprietary Name | Brimonidine Tartrate |
| Package Description | 5 mL in 1 BOTTLE (61314-143-05) |
| Product NDC | 61314-143 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Brimonidine Tartrate |
| Dosage Form Name | SOLUTION |
| Route Name | OPHTHALMIC |
| Start Marketing Date | 20030917 |
| Marketing Category Name | ANDA |
| Labeler Name | Falcon Pharmaceuticals, Ltd. |
| Substance Name | BRIMONIDINE TARTRATE |
| Strength Number | 2 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Adrenergic alpha-Agonists [MoA],alpha-Adrenergic Agonist [EPC] |
